Access all MSDS in one place!

The new MSDS Database Online—updated daily.

Highlights

Drug brand name changed due to mix-ups identified through reports to USP and FDA Reports to USP's MEDMARX and Medication Errors Reporting Program and the FDA helped to identify a serious problem involving mix-ups between Reminyl, a drug used for Alzheimer's and Amaryl, a drug used to treat diabetes. As a result, the Reminyl brand name is changing to Razadyne.

Page Cannot Be Found

The page you requested on the USP Web site has been moved or was not found.

You can also browse the site by starting at the homepage or, by visiting a specific section of the site such as:

If you still have not found the information you need, try our search option in the top right corner of this page.

If you have any questions regarding this page or others on the USP.org Web site, please to USP.

We appreciate your visit and have designed this page to direct you to the information you need.